| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Annexon, Inc.
13D/A
ANNX · 03589W102
|
7.2% |
11/21/2025
Event 11/19/2025
|
||||
| Schedule 13G · 2 securities · passive | ||||||
|
Akebia Therapeutics, Inc.
13G/A
AKBA · 00972D105
|
2.6% |
2/14/2025
Event 12/31/2024
|
||||
|
Aadi Bioscience, Inc.
13G/A
WHWK · 00032Q104
|
0% |
2/14/2025
Event 12/31/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.